• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112
Citation: XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112
shu

Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis

More Information
    Graphical Abstract
    • Abstract
  • This study aimed to investigate the protective effect of total alkaloids(TA)and one of the active components, neotuberostemonine, of Stemona tuberosa on bleomycin-induced pulmonary fibrosis in mice and to explore the mechanism by fibroblasts model. The bleomycin-induced mice were orally administered with TA(60 mg/kg)and neotuberostemonine(10, 20 mg/kg), with prednisone(6. 67 mg/kg)as a positive control. The anti-fibrotic effects were assessed by hydroxyproline content, TGF-β1 level, inflammatory score, collagen deposition and the expression of α-SMA in the lung tissues. The results revealed that TA and neotuberostemonine could significantly ameliorate the inflammation and injury, and attenuate the hydroxyproline content and collagen deposition. Moreover, neotuberostemonine treatment markedly down-regulated the α-SMA level and TGF-β1 content in bleomycin-injured mice lungs. The in vitro experiments showed that neotuberostemonine inhibited the expression of α-SMA induced by TGF-β1 in a dose-dependent manner, indicating that suppression on differentiation of fibroblasts to myofibroblasts may be one of the mechanisms for neotuberostemonine against pulmonary fibrosis.
    • FullText(HTML)
    • References (16)
  • [1]
    Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis[J].Annu Rev Pathol,2014,9:157-179.
    [2]
    Karimi-Shah BA,Chowdhury BA.Forced vital capacity in idiopathic pulmonary fibrosis—FDA review of pirfenidone and nintedanib[J].N Engl J Med,2015,372(13):1189-1191.
    [3]
    Lekkerkerker AN,Aarbiou J,van Es T,et al.Cellular players in lung fibrosis[J].Curr Pharm Des,2012,18(27):4093-4102.
    [4]
    Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 1(中华人民共和国药典:一部)[S].Beijing:China Medical Science Press,2015:132.
    [5]
    Gao Y,Wang J,Zhang CF,et al.Seven new alkaloids from the roots of Stemona tuberosa[J]. Tetrahedron,2014,70(4):967-974.
    [6]
    Chung HS,Hon PM,Lin G,et al.Antitussive activity of Stemona alkaloids from Stemona tuberosa[J].Planta Med,2003,69(10):914-920.
    [7]
    Sun H,Dong W,Zhang A,et al.Ultra-performance liquid-chromatography with tandem mass spectrometry performing pharmacokinetic and biodistribution studies of croomine,neotuberostemonine and tuberostemonine alkaloids absorbed in the rat plasma after oral administration of Stemonae Radix[J].Fitoterapia,2012,83(8):1699-1705.
    [8]
    Lv XX,Wang XX,Li K,et al.Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents[J]. PLoS ONE,2013,8(7):e68631.
    [9]
    You XY,Xue Q,Fang Y,et al.Preventive effects of Ecliptae Herba extract and its component,ecliptasaponin A,on bleomycin-induced pulmonary fibrosis in mice[J].J Ethnopharmacol,2015,175:172-180.
    [10]
    Seluanov A,Vaidya A,Gorbunova V.Establishing primary adult fibroblast cultures from rodents[J].J Vis Exp,2010(44):2033.
    [11]
    Jung KH,Choi HL,Park S,et al.The effects of the standardized herbal formula PM014 on pulmonary inflammation and airway responsiveness in a murine model of cockroach allergen-induced asthma[J].J Ethnopharmacol,2014,155(1):113-122.
    [12]
    Wei JS,Li JY,Mei RH,et al.Influence of the extract of Compound Formula Rosin and Bletilla Table in bleomycin induced pulmonary fibrosis in mice[J].China Med Her(中国医药导报),2012,9(28):24-26.
    [13]
    Lim D,Lee E,Jeong E,et al.Stemona tuberosa prevented inflammation by suppressing the recruitment and the activation of macrophages in vivo and in vitro[J].J Ethnopharmacol,2015,160:41-51.
    [14]
    Raghu G,Collard HR,Egan JJ,et al.An official ATS/ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J].Am J Respir Crit Care Med,2011,183(6):788-824.
    [15]
    Roy SG,Nozaki Y,Phan SH.Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts[J].Int J Biochem Cell Biol,2001,33(7):723-734.
    [16]
    Della Latta V,Cecchettini A,Del Ry S,et al.Bleomycin in the setting of lung fibrosis induction:from biological mechanisms to counteractions[J].Pharmacol Res,2015,97:122-130.
    • Related Articles

  • Related Articles

    [1]WANG Songkai, ZOU Yuchen, SUN Shipeng, YAN Zhiye, TANG Weiwei, LI Ping, LI Bin. Recent advances in mass spectrometry imaging and its application in drug research[J]. Journal of China Pharmaceutical University, 2023, 54(6): 653-661. DOI: 10.11665/j.issn.1000-5048.2023091901
    [2]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [3]ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403
    [4]WEI Yuanyuan, YANG Fan, TANG Jie, YU Lifang. Advances in the research of anti-tuberculosis drugs[J]. Journal of China Pharmaceutical University, 2020, 51(2): 231-239. DOI: 10.11665/j.issn.1000-5048.20200215
    [5]HAN Xiu, QI Xiaole, WU Zhenghong. Advances in self-assemblied DNA nanocages as drug delivery systems[J]. Journal of China Pharmaceutical University, 2017, 48(6): 663-669. DOI: 10.11665/j.issn.1000-5048.20170605
    [6]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [7]JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418
    [8]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [9]LIU Yanhong, ZHOU Jianping, HUO Meirong. Advances in the tumor microenvironment-responsive smart drug delivery nanosystem[J]. Journal of China Pharmaceutical University, 2016, 47(2): 125-133. DOI: 10.11665/j.issn.1000-5048.20160201
    [10]WANG Ruoning, LIU Congyan, ZHOU Jianping, CHEN Jian, WANG Wei. Advances in the research of lipoprotein-based nano scale drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(1): 10-16. DOI: 10.11665/j.issn.1000-5048.20140102

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365726

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return